Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)
- Conditions
- Dental PlaqueGingivitis
- Interventions
- Drug: Triclosan/fluoride toothpasteDrug: stannous fluoride toothpasteDrug: fluoride only toothpasteDrug: Fluoride only mouthwash
- Registration Number
- NCT02366689
- Lead Sponsor
- Colgate Palmolive
- Brief Summary
The objective of this clinical research study is to assess the efficacy of a commercially available triclosan/copolymer toothpaste compared to a commercially available oral hygiene multi-component regimen encompassing the use of a manual toothbrush, a toothpaste containing stannous fluoride / sodium hexametaphosphate and a mouthwash containing cetylpyridinium chloride relative to a negative control regimen in reducing established dental plaque and gingivitis over three and six months of assigned product use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 179
- Male and female subjects, ages 18-70, inclusive.
- Availability for the six-month duration of the study.
- Good general health.
- Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
- Signed Informed Consent Form.
- Presence of orthodontic bands.
- Presence of partial removable dentures.
- Tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
- Five or more carious lesions requiring immediate restorative treatment.
- Use of antibiotics any time during the one month prior to entry into the study.
- Participation in any other clinical study or test panel within the one month prior to entry into the study.
- Pregnant women or women who are breast feeding.
- Dental prophylaxis received in the past two weeks prior to baseline examinations.
- History of allergies to oral care/personal care consumer products or their ingredients.
- On any prescription medicines that might interfere with the study outcome.
- An existing medical condition which prohibits eating or drinking for periods up to 4 hours.
- History of alcohol or drug abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Toothpaste Triclosan/fluoride toothpaste Triclosan/fluoride toothpaste Toothpaste + mouthwash stannous fluoride toothpaste stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash Toothpaste + mouthwash Cetylpyridinium chloride mouthwash stannous fluoride toothpaste + cetylpyridinium chloride Mouthwash Fluoride only Toothpaste + mouthwash fluoride only toothpaste Fluoride only toothpaste + Fluoride only Mouthwash Fluoride only Toothpaste + mouthwash Fluoride only mouthwash Fluoride only toothpaste + Fluoride only Mouthwash
- Primary Outcome Measures
Name Time Method Gingivitis Scores 6 months Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)
Dental Plaque Scores 6 months Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Concordia Clinical Research
🇺🇸Cedar Knolls, New Jersey, United States